Overview

Acute kidney injury treatment market is expected to value over USD 1.8 billion by 2027 end and register a CAGR of over 6.4% during the forecast period 2020-2027.

Increasing technological advancements, rising geriatric population, and increasing patient population remain the major factors stimulating the market growth. Technological advancements coupled with rising research and development activities are expected to expand the acute kidney injury treatment market size.

Favorable initiatives launched by governments is expected to be the new acute kidney treatment injury treatment market trend.

The market is bifurcated on the basis of type, end-user, and region. In terms of type, prerenal acute kidney injury is expected to hold a major acute kidney injury treatment market share. Rise in the geriatric population and increasing cases of heart failure have contributed towards the market growth. Additionally, low blood pressure and liver cirrhosis are also factors burgeoning market growth.

In terms of end-user, hospitals control the growth of the market. The rapid expansion of hospitals in developed economies alongside favorable government initiatives is fueling the acute kidney injury treatment market growth as well.

Based on regions, acute kidney injury treatment market size is expected to multiply in the North America region. The availability of efficient and developed healthcare infrastructure remains the key factor in escalating the market growth in the region. Increasing government approval is also spiking the market in the region. Rapidly increasing clinical pipeline and growing patient population are propelling the market proliferation in the growth.

Asia-Pacific is also projected to be a lucrative region owing to the large penetration of prominent players and rapidly expanding the healthcare sector in the region. Increasing geriatric population in countries like Japan and China is expected to drive the market growth. Growing urbanization and rising critical care admissions are expected to positively influence the market. 

Prominent players of the market are AM-Pharma, Fresenius Medical Care AG & Co. KgaA., LG Chem., Asahi Kasei Medical, Angion Biomedia Corp., Baxter International, Inc., B.Braun Melsungen AG and Quark Pharmaceuticals, Inc. 

Global Acute Kidney Injury Treatment Market Segmentation:

By Type 

● Prerenal Acute Kidney Injury 

● Intrinsic Renal Acute Kidney Injury

● Postrenal Acute Kidney Injury 

 

By End-User 

● Hospitals 

● Ambulatory Surgical Centers 

● Others 

 

By Region

● North America

● Europe

● Asia Pacific

● Latin America

● Middle East & Africa

 

FutureWise Key Takeaways:

● Dialysis sector is expected to create a vast impact on the market as it's essential for critically ill patients

● Expansion of dialysis centers worldwide is expected to drive the market

● The governments of developing economies are setting up new dialysis centers, thus propelling the acute kidney injury treatment market growth

● Abu Dhabi Services Company and Abu Dhabi General Services Company announced to establish a state-of-the-art dialysis center in UAE. The centre would contain units of 65 kidney dialysis. As a result, increasing in number of dialysis centers offers immense opportunities for market growth

 

Objectives of the Study:

● To provide with an exhaustive analysis on acute kidney injury treatment market by end-user, by type and by region

● To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)

● To evaluate and forecast micro-markets and the overall market 

● To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Latin America and Middle East & Africa

● To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions

● Profiling of companies to evaluate their market shares, strategies, financials and core competencies

 

Table of Contents

 1. Introduction 

        1.1. Report Scope and Market Segmentation 

        1.2. Research Highlights

    2. Assumptions and Research Methodology 

        2.1. Assumptions and Acronyms Used

        2.2. Research Methodology

    3. Executive Summary

        3.1. Global Market Snapshot

    4. Market Overview

        4.1. Global Market: Overview 

        4.2. Global Market: Key Industry Developments

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Market Revenue Projection

        4.5. Global Market Outlook

    5. Market Outlook

        5.1. Acute Kidney Injury Epidemiology: Overview

        5.2. Merger and Acquisition Deals

        5.3. Pipeline Analysis

    6. Global Acute Kidney Injury Treatment Market Analysis, by Treatment

        6.1. Key Findings

        6.2. Introduction

        6.3. Global Market Value Share and Attractiveness Analysis, by Treatment

        6.4. Global Market Value Forecast, by Treatment

            6.4.1. Dialysis

            6.4.2. Supportive Care

        6.5. Global Market Analysis, by Treatment 

    7. Global Acute Kidney Injury Treatment Market Analysis and Forecasts, by Type

        7.1. Key Findings

        7.2. Introduction

        7.3. Global Market Value Share and Attractiveness Analysis, by Type

        7.4. Global Market Value Forecast, by Type

            7.4.1. Prerenal Acute Kidney Injury

            7.4.2. Intrinsic Renal Acute Kidney Injury

            7.4.3. Postrenal Acute Kidney Injury

        7.5. Global Market Analysis, by Type

    8. Global Acute Kidney Injury Treatment Market Analysis, by End-user

        8.1. Key Findings

        8.2. Introduction

        8.3. Global Market Value Share and Attractiveness Analysis, by End-user

        8.4. Global Market Value Forecast, by End-user

            8.4.1. Hospitals

            8.4.2. Ambulatory Surgical Centers

            8.4.3. Others

        8.5. Global Market Analysis, by End-user

    9. Global Acute Kidney Injury Treatment Market Analysis, by Region

        9.1. Global Market Scenario, by Country

        9.2. Global Market Value Share and Attractiveness Analysis, by Region

        9.3. Global Market Value Forecast, by Region

            9.3.1. North America

            9.3.2. Europe

            9.3.3. Asia Pacific 

            9.3.4. Latin America

            9.3.5. Middle East & Africa

    10. North America Market Analysis

        10.1. Key Findings

        10.2. North America Market Overview

        10.3. North America Market Value Share and Attractiveness Analysis, by Country

        10.4. North America Market Forecast, by Country

            10.4.1. U.S.

            10.4.2. Canada

        10.5. North America Market Value Share Analysis, by Treatment

        10.6. North America Market Forecast, by Treatment

            10.6.1. Dialysis

            10.6.2. Supportive Care

        10.7. North America Market Value Share Analysis, by Type

        10.8. North America Market Forecast, by Type

            10.8.1. Prerenal Acute Kidney Injury

            10.8.2. Intrinsic Renal Acute Kidney Injury

            10.8.3. Postrenal Acute Kidney Injury

        10.9. North America Market Value Share Analysis, by End-user

        10.10. North America Market Forecast, by End-user

            10.10.1. Hospitals

            10.10.2. Ambulatory surgical centers

            10.10.3. Others

        10.11. North America Market Attractiveness Analysis

    11. Europe Market Analysis

        11.1. Key Findings

        11.2. Europe Market Overview

        11.3. Europe Market Value Share and Attractiveness Analysis, by Country/Sub-region

        11.4. Europe Market Forecast, by Country/Sub-region

            11.4.1. Germany

            11.4.2. U.K.

            11.4.3. France

            11.4.4. Italy

            11.4.5. Spain

            11.4.6. Rest of Europe

        11.5. Europe Market Value Share Analysis, by Treatment

        11.6. Europe Market Forecast, by Treatment

            11.6.1. Dialysis

            11.6.2. Supportive Care

        11.7. Europe Market Value Share Analysis, by Type

        11.8. Europe Market Forecast, by Type

            11.8.1. Prerenal Acute Kidney Injury

            11.8.2. Intrinsic Renal Acute Kidney Injury

            11.8.3. Postrenal Acute Kidney Injury

        11.9. Europe Market Value Share Analysis, by End-user

        11.10. Europe Market Forecast, by End-user

            11.10.1. Hospitals

            11.10.2. Ambulatory Surgical Centers

            11.10.3. Others

        11.11. Europe Market Attractiveness Analysis

    12. Asia Pacific Market Analysis

        12.1. Key Findings

        12.2. Asia Pacific Market Overview

        12.3. Asia Pacific Market Value Share and Attractiveness Analysis, by Country/Sub-region

        12.4. Asia Pacific Market Forecast, by Country/Sub-region

            12.4.1. China

            12.4.2. India

            12.4.3. Japan

            12.4.4. Australia & New Zealand

            12.4.5. Rest of Asia Pacific

        12.5. Asia Pacific Market Value Share Analysis, by Treatment

        12.6. Asia Pacific Market Forecast, by Treatment

            12.6.1. Dialysis

            12.6.2. Supportive Care

        12.7. Asia Pacific Market Value Share Analysis, by Type

        12.8. Asia Pacific Market Forecast, by Type

            12.8.1. Prerenal Acute Kidney Injury

            12.8.2. Intrinsic Renal Acute Kidney Injury

            12.8.3. Postrenal Acute Kidney Injury

        12.9. Asia Pacific Market Value Share Analysis, by End-user

        12.10. Asia Pacific Market Forecast, by End-user

            12.10.1. Hospitals

            12.10.2. Ambulatory Surgical Centers

            12.10.3. Others

        12.11. Asia Pacific Market Attractiveness Analysis

    13. Latin America Market Analysis

        13.1. Key Findings

        13.2. Latin America Market Overview

        13.3. Latin America Market Value Share and Attractiveness Analysis, by Country/Sub-region

        13.4. Latin America Market Forecast, by Country/Sub-region

            13.4.1. Brazil

            13.4.2. Mexico

            13.4.3. Rest of Latin America

        13.5. Latin America Market Value Share Analysis, by Treatment

        13.6. Latin America Market Forecast, by Treatment

            13.6.1. Dialysis

            13.6.2. Supportive Care

        13.7. Latin America Market Value Share Analysis, by Type

        13.8. Latin America Market Forecast, by Type

            13.8.1. Prerenal Acute Kidney Injury

            13.8.2. Intrinsic Renal Acute Kidney Injury

            13.8.3. Postrenal Acute Kidney Injury

        13.9. Latin America Market Value Share Analysis, by End-user

        13.10. Latin America Market Forecast, by End-user

            13.10.1. Hospitals

            13.10.2. Ambulatory Surgical Centers

            13.10.3. Others

        13.11. Latin America Market Attractiveness Analysis

    14. Middle East & Africa Market Analysis

        14.1. Key Findings

        14.2. Middle East & Africa Market Overview

        14.3. Middle East & Africa Market Value Share Analysis, by Country/Sub-region

        14.4. Middle East & Africa Market Forecast, by Country/Sub-region

            14.4.1. GCC Countries

            14.4.2. South Africa

            14.4.3. Rest of Middle East and Africa

        14.5. Middle East & Africa Market Value Share Analysis, by Treatment

        14.6. Middle East & Africa Market Forecast, by Treatment

            14.6.1. Dialysis

            14.6.2. Supportive Care

        14.7. Middle East & Africa Market Value Share Analysis, by Type

        14.8. Middle East & Africa Market Forecast, by Type

            14.8.1. Prerenal Acute Kidney Injury

            14.8.2. Intrinsic Renal Acute Kidney Injury

            14.8.3. Postrenal Acute Kidney Injury

        14.9. Middle East & Africa Market Value Share Analysis, by End-user

        14.10. Middle East & Africa Market Forecast, by End-user

            14.10.1. Hospitals

            14.10.2. Ambulatory Surgical Centers

            14.10.3. Others

        14.11. Middle East & Africa Market Attractiveness Analysis

    15. Competition Landscape

        15.1. Market Share Analysis, by Company, 2016

        15.2. Competition Matrix

        15.3. Company Profiles

            15.3.1. Angion Biomedica Corp

                15.3.1.1. Company Details

                15.3.1.2. Business Overview

                15.3.1.3. Financial Overview

                15.3.1.4. Strategic Overview

                15.3.1.5. SWOT Analysis

            15.3.2. AM-Pharma

                15.3.2.1. Company Details

                15.3.2.2. Business Overview

                15.3.2.3. Financial Overview

                15.3.2.4. Strategic Overview

                15.3.2.5. SWOT Analysis

            15.3.3. Quark Pharmaceuticals, Inc

                15.3.3.1. Company Details

                15.3.3.2. Business Overview

                15.3.3.3. Financial Overview

                15.3.3.4. Strategic Overview

                15.3.3.5. SWOT Analysis

            15.3.4. Baxter International, Inc.

                15.3.4.1. Company Details

                15.3.4.2. Business Overview

                15.3.4.3. Financial Overview

                15.3.4.4. Strategic Overview

                15.3.4.5. SWOT Analysis

            15.3.5. Fresenius Medical Care AG & Co. KGaA

                15.3.5.1. Company Details

                15.3.5.2. Business Overview

                15.3.5.3. Financial Overview

                15.3.5.4. Strategic Overview

                15.3.5.5. SWOT Analysis

            15.3.6. LG Chem

                15.3.6.1. Company Details

                15.3.6.2. Business Overview

                15.3.6.3. Financial Overview

                15.3.6.4. Strategic Overview

                15.3.6.5. SWOT Analysis

            15.3.7. Asahi Kasei Medical Co., Ltd

                15.3.7.1. Company Details

                15.3.7.2. Business Overview

                15.3.7.3. Financial Overview

                15.3.7.4. Strategic Overview

                15.3.7.5. SWOT Analysis

            15.3.8. B. Braun Melsungen AG

                15.3.8.1. Company Details

                15.3.8.2. Business Overview

                15.3.8.3. Financial Overview

                15.3.8.4. Strategic Overview

                15.3.8.5. SWOT Analysis

 

Chapter 16 Research Finding and Conclusion 

 

Chapter 17  Research Methodology 

 

Chapter 18  Research Data Source  

 

 

Tables

Figures